Overview
Zheng Topp is a Hematologist Oncology specialist and an Oncologist in Portland, Oregon. Dr. Topp is rated as an Experienced provider by MediFind in the treatment of Polycythemia Vera. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Topp is currently accepting new patients.
Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- PPO
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Oregon Oncology Specialists Llp
William Pierce is a Hematologist and an Oncologist in Mcminnville, Oregon. Dr. Pierce is rated as a Distinguished provider by MediFind in the treatment of Polycythemia Vera. His top areas of expertise are Familial Colorectal Cancer, Gallbladder Cancer, Gallbladder Adenocarcinoma, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.
Kelly Perlewitz is a Hematologist and an Oncologist in Newberg, Oregon. Dr. Perlewitz is rated as a Distinguished provider by MediFind in the treatment of Polycythemia Vera. Her top areas of expertise are Angiosarcoma, Appendix Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Perlewitz is currently accepting new patients.
Gary Cecchi is a Hematologist Oncology specialist and a Hematologist in Vancouver, Washington. Dr. Cecchi is rated as a Distinguished provider by MediFind in the treatment of Polycythemia Vera. His top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Thrombotic Thrombocytopenic Purpura.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Topp isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Topp isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Topp isAdvanced. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Topp isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Eosinophilic PneumoniaDr. Topp isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Topp isExperienced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung Cancer
- Ampullary CancerDr. Topp isExperienced. Learn about Ampullary Cancer.
- AnemiaDr. Topp isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaDr. Topp isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.